KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Asset Utilization Ratio (2016 - 2025)

Arbutus Biopharma's Asset Utilization Ratio history spans 12 years, with the latest figure at 0.15 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 223.9% year-over-year to 0.15; the TTM value through Sep 2025 reached 0.15, up 223.9%, while the annual FY2024 figure was 0.04, 58.13% down from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.15 at Arbutus Biopharma, up from 0.14 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.2 in Q4 2022 and bottomed at 0.04 in Q3 2024.
  • The 5-year median for Asset Utilization Ratio is 0.12 (2023), against an average of 0.11.
  • The largest annual shift saw Asset Utilization Ratio plummeted 66.16% in 2024 before it skyrocketed 223.9% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.06 in 2021, then surged by 229.6% to 0.2 in 2022, then tumbled by 38.75% to 0.12 in 2023, then crashed by 62.12% to 0.05 in 2024, then soared by 220.5% to 0.15 in 2025.
  • Per Business Quant, the three most recent readings for ABUS's Asset Utilization Ratio are 0.15 (Q3 2025), 0.14 (Q2 2025), and 0.05 (Q1 2025).